JENNIFER GALAN: Open Payments
NPI 1740662071 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$477 in 18 payments from 7 companies in 2025. Trend: 2023 $230 · 2024 $650 · 2025 $477
Food & beverage: $477
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $120 |
| CVRx, Inc. | 1 | $108 |
| GENZYME CORPORATION | 4 | $100 |
| Janssen Biotech, Inc. | 4 | $95 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: Barostim Neo System, DUPIXENT, TREMFYA, RINVOQ, SKYRIZI, LEQVIO, GEMTESA, VIBERZI.
Industry payments across FL — which companies pay providers there.
